Hjertealbyl 75 mg enterotabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

hjertealbyl 75 mg enterotabletter

teva b.v. - acetylsalicylsyre - enterotabletter - 75 mg

Hjertemagnyl 150 mg filmovertrukne tabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

hjertemagnyl 150 mg filmovertrukne tabletter

orifarm healthcare a/s - acetylsalicylsyre - filmovertrukne tabletter - 150 mg

Hjertemagnyl 75 mg filmovertrukne tabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

hjertemagnyl 75 mg filmovertrukne tabletter

orifarm healthcare a/s - acetylsalicylsyre - filmovertrukne tabletter - 75 mg

Hjertemin 75 mg tabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

hjertemin 75 mg tabletter

viatris aps - acetylsalicylsyre - tabletter - 75 mg

Magnyl "DAK" 100 mg enterotabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

magnyl "dak" 100 mg enterotabletter

orifarm healthcare a/s - acetylsalicylsyre - enterotabletter - 100 mg

Magnyl "DAK" 500 mg tabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

magnyl "dak" 500 mg tabletter

orifarm healthcare a/s - acetylsalicylsyre - tabletter - 500 mg

Magnyl Svage "DAK" 150 mg filmovertrukne tabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

magnyl svage "dak" 150 mg filmovertrukne tabletter

orifarm healthcare a/s - acetylsalicylsyre - filmovertrukne tabletter - 150 mg

Hjertealbyl 75 mg enterotabletter Danmörk - danska - Lægemiddelstyrelsen (Danish Medicines Agency)

hjertealbyl 75 mg enterotabletter

2care4 aps - acetylsalicylsyre - enterotabletter - 75 mg

Orkambi Evrópusambandið - danska - EMA (European Medicines Agency)

orkambi

vertex pharmaceuticals (ireland) limited - lumacaftor, ivacaftor - cystisk fibrose - andet respirationssystem produkter - orkambi tabletter er indiceret til behandling af cystisk fibrose (cf) hos patienter i alderen 6 år og ældre, der er homozygot for f508del-mutation i cftr-genet. orkambi granules are indicated for the treatment of cystic fibrosis (cf) in children aged 1 year and older who are homozygous for the f508del mutation in the cftr gene.

Zoledronic acid Teva Pharma Evrópusambandið - danska - EMA (European Medicines Agency)

zoledronic acid teva pharma

teva b.v. - zoledronsyre - osteoporosis; osteitis deformans; osteoporosis, postmenopausal - narkotika til behandling af knoglesygdomme - treatment of osteoporosis: , in post-menopausal women;, in men; , at increased risk of fracture including those with a recent low-trauma hip fracture. treatment of osteoporosis associated with long-term systemic glucocorticoid therapy: , in post-menopausal women;, in men; , at increased risk of fracture. behandling af pagets sygdom af knoglerne hos voksne.